“Every Stock I'm Buying in September 2026 (Huge Opportunities)”
$HRBullish
HR is a top-tier healthcare real estate play; current price drop, 5% dividend, and valuation support a long-term rebound thesis.
Now, we did also though have some pretty high votes for two brand new, what would be brand new additions in Prologess and Healthcare Realy HR. And so, I actually decided to add both of those as well.
So, I did buy Vichy. I did purchase more of them, but I also added Prolois and Healthcare Realy as two brand new additions.